Page last updated: 2024-12-08

n-formylmethionine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-formyl-L-methionine : A L-methionine derivative in which one of the hydrogens attached to the nitrogen is replaced by a formyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID439750
CHEBI ID16552
SCHEMBL ID38595
MeSH IDM0014395

Synonyms (41)

Synonym
nsc-334322
N-FORMYLMETHIONINE ,
n-formyl-l-methionine
C03145
4289-98-9
formylmethionine
DB04464
(2s)-2-(formylamino)-4-(methylthio)butanoic acid
formyl-methionine
l-n-formylmethionine
fmet
CHEBI:16552
(2s)-2-formamido-4-(methylsulfanyl)butanoic acid
n-formyl methionine
methionine, n-formyl-
2CF0FBDF-3637-4C59-9B20-129171405E12
F0124
for-met-oh
nsc 334322
formyl-l-methionine
l-methionine, n-formyl-
unii-ps9357b4xh
l-formylmethionine
ps9357b4xh ,
S3328
SCHEMBL38595
n-formyl-l-met
AKOS016843650
(s)-2-formamido-4-(methylthio)butanoic acid
n-formyl(methyl)homocysteine #
(2s)-2-formamido-4-(methylthio)butyric acid
(2s)-2-formamido-4-methylsulfanyl-butanoic acid
mfcd00021033
DTXSID80863357
Q63390516
HY-W016647
F10890
AS-46910
CS-W017363
EN300-7287060
Z760037304

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Comparison of PMN and macrophages from different species showed that the maximal chemiluminescent response seen in the dose-response curve of F-Met- Phe was different in different cell types."( Chemiluminescence of phagocytic cells caused by N-formylmethionyl peptides.
Gardner, DE; Hatch, GE; Menzel, DB, 1978
)
0.26
" The relevance of this reaction to secretory phenomena is indicated by its requirement for Ca, its rapid onset, and dose-response curves that paralleled those of the secretory response."( Calcium-phospholipid interactions in secretory cells: a new perspective on stimulus-secretion coupling.
Rubin, RP, 1982
)
0.26
"The dose-response characteristics of the neutrophil 3-3'-dipentyloxacarbocyanine (di-O-C5(3)) fluorescence response to repetitive stimulation with the chemoattractant N-formylmethionylleucylphenylalanine (fMet-Leu-Phe) were studied."( Adaptation of human neutrophil responsiveness to the chemoattractant N-formylmethionylleucylphenylalanine. Heterogeneity and/or negative cooperative interaction of receptors.
Fletcher, MP; Gallin, JI; Seligmann, BE, 1982
)
0.26
" This secretory response was normal as judged by cell ultrastructure and FMLP dose-response relationships."( FMLP-induced enzyme release from neutrophils: a role for intracellular calcium.
Chandler, D; Meusel, G; Schumaker, E; Stapleton, C, 1983
)
0.27
" Time- and dose-response relationships for neutrophil bipolar shape formation (BSF) agree with data reported for other neutrophil response measurements."( Neutrophil bipolar shape formation in whole blood. A simple and rapid method for the assessment of neutrophil leukocyte responsiveness.
Jadwin, DF; Meadows, TR; Smith, CW, 1981
)
0.26
" Dose-response experiments performed with 2 to 90 per cent (v/v) zymosan-activated plasma showed a direct correlation between the rate of neutrophil influx and the degree of vascular permeability in blood flow."( Vascular responses during acute neutrophilic inflammation. Their relationship to in vivo neutrophil emigration.
Issekutz, AC, 1981
)
0.26
" The cell dose-response was linear for both preparations over a wide range of cell concentrations in the cell input well of the chemotaxis chamber, suggesting that no monocyte-monocyte interaction was required."( Chemotaxis of purified human monocytes in vitro: lack of accessory cell requirement.
Falk, W; Leonard, EJ, 1982
)
0.26
" Dose-response curves to the synthetic chemotactic agent Formyl-Methionyl-Leucyl-Phenylalanine (FMLP) showed decreased response to submaximal chemokinetic stimuli in stored neutrophils."( Decreased affinity for a chemotactic factor in stored granulocyte concentrates.
Lane, TA; Windle, BE,
)
0.13
" Similar dose-response curves for esterase activation, chemotaxis, and chemotactic deactivation were obtained with the chemotactic factor FMLP, suggesting that in human neutrophils all three functions utilize some of the same early molecular events following chemotactic factor binding to th neutrophil surface."( Demonstration of calcium-dependent chemotactic factor activatable esterase activity in human neutrophils: relationship with chemotaxis and chemotactic deactivation.
Kleyman, T; Mandell, B; Mehta, J; Spilberg, I, 1981
)
0.26
" Dose-response studies under comparable conditions showed that aggregation is induced in similar dose ranges as chemotaxis."( Aggregation of leukocytes induced by the complement-derived peptides C3a and C5a and by three synthetic formyl-methionyl peptides.
Damerau, B; Grünefeld, E; Vogt, W, 1980
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
proteinogenic amino acidAny of the 23 alpha-amino acids that are precursors to proteins, and are incorporated into proteins during translation. The group includes the 20 amino acids encoded by the nuclear genes of eukaryotes together with selenocysteine, pyrrolysine, and N-formylmethionine. Apart from glycine, which is non-chiral, all have L configuration.
N-formyl amino acidAny N-acyl amino acid which has formyl as the acyl group.
L-methionine derivativeA proteinogenic amino acid derivative resulting from reaction of L-methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-methionine by a heteroatom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (507)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990438 (86.39)18.7374
1990's32 (6.31)18.2507
2000's25 (4.93)29.6817
2010's7 (1.38)24.3611
2020's5 (0.99)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 53.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index53.29 (24.57)
Research Supply Index6.25 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index87.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (53.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews20 (3.88%)6.00%
Case Studies2 (0.39%)4.05%
Observational0 (0.00%)0.25%
Other493 (95.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]